Published in Gene Therapy Weekly, August 18th, 2005
The treatment might also reduce the number of amputations of toes and feet if early effects on nerve protection and regeneration are borne out long-term. Nerve disease in diabetes is the major cause of nontraumatic lower limb amputations in Europe and North America.
Scientists at the University of Manchester, working with colleagues at American biotech firm Sangamo BioSciences, have discovered a way of stimulating genes that prevent nerve damage caused by the disease.
Professor David Tomlinson, who is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.